SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Vasogen-- VAS on TSE -- Ignore unavailable to you. Want to Upgrade?

To: Syncrude who wrote (81)12/18/1997 1:50:00 AM
From: cann11  Read Replies (2) | Respond to of 377
 
I think this stock should be traded in the nasdaq so more people would know about it!! Don't you guys agree with me. I want some replies . Thanks!



To: Syncrude who wrote (81)12/18/1997 7:19:00 AM
From: stevie  Read Replies (2) | Respond to of 377
 
Patrick:
I am under the impression that Vasogen had purchased the exclusive rights to this therapy from its German developer. They have been working on this technology with clinical trials for a long time. I have never heard of any other company pursing this form of treatment.
Please, tell me who is competeing with Vasogen??? so I can do some investigation.

Thanks

Regards

Stevie


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News